MAZE
Maze Therapeutics, Inc.
25.90$
-1.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 47.7% | – | 83.1% | 80.0% | 83.8% | 90.0% | 89.3% | 92.7% | 88.1% | 90.5% | 79.1% | |
| – | 40.8% | – | 81.1% | 77.7% | 81.8% | 88.4% | 87.2% | 75.1% | 47.7% | 47.4% | 38.1% | |
| – | 40.8% | – | 81.1% | 77.7% | 81.8% | 88.4% | 87.2% | 91.0% | 86.1% | 84.0% | 77.3% | |
| – | – | – | – | – | – | – | – | 0.2% | 0.4% | 4.8% | 0.5% | |
| – | 85.9% | – | 221.6% | 48.4% | 18.1% | 12.2% | 13.6% | 10.1% | 10.6% | 18.6% | 14.8% | |
| – | 22.8% | – | 10.0% | 9.1% | 8.6% | 5.6% | 6.6% | 5.2% | 5.7% | 5.1% | 4.3% | |
| – | 6.3% | – | 2.1% | 2.4% | 1.9% | 1.4% | 1.6% | 1.1% | 1.2% | 1.2% | 0.9% | |
| – | 2.8% | – | 1.0% | 0.5% | 0.8% | 0.7% | 1.2% | 0.7% | 0.5% | 1.0% | 0.4% | |
| – | 28.1% | – | 22.8% | 26.9% | – | – | – | – | – | 9.3% | 7.3% | |
| – | 14.1% | – | -121.6% | 51.6% | 81.9% | 87.8% | 86.4% | 89.9% | 89.4% | 81.4% | 85.2% | |
| – | -553.4% | – | -134.0% | -163.1% | -149.0% | -117.5% | -140.0% | -107.8% | -123.3% | -122.4% | -105.1% | |
| – | 61.2% | – | 20.3% | 22.7% | 18.2% | 13.2% | 14.4% | 10.8% | 10.8% | 12.8% | 11.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.